EquityFlow
›
Companies
› Ori Biotech
Ori Biotech
Biotech
· London, GB
Cell and gene therapy manufacturing platform
Funding history
Date
Round
Amount
Jan 2022
Series B
Ori Biotech raised over USD100M Series B led by Novalis LifeSciences.
$100M
Investors
Novalis LifeSciences
Octopus Ventures
Similar companies in Biotech
Imperagen
Haga Bioscience
Pixelgen Technologies
Gallant
Chai Discovery
SNIPR Biome
Cellbox Labs
Scope Biosciences
GenLumina
Actithera
NUCLIDIUM
Anocca
Explore funding flow on EquityFlow →